Cramer finds it difficult to overstate the contempt and anger that most executives feel about Valeant — the company that he considers to have singlehandedly created an entire bear market for drug stocks.
Only on rare days like Friday when Valeant actually rallied, is there a respite to the selling of the whole group.
"Every day that Valeant's awful business practices stay front and center in the public eye is another day that these guys know they are doomed to an era of lower profitability," the "Mad Money" host said.
So, with a new quarter now beginning on Wall Street and Bernie Sanders still running longer than Cramer thought, Valeant still has the ability to cause mayhem for the stock market. The damage seems completely unchecked to Cramer, with only the occasional up day for Valeant providing any relief.
The problem is that Valeant won't go down without swinging, and as long as it remains on its feet, the drug group simply cannot advance for any sustained period of time.
Read More Cramer: Valeant must go down for pharma to rally
Cramer has officially deemed Friday, "speculation Friday," where he highlights the high-risk high-reward stocks that could be worth trading in.
The caveat, he said, is that these stocks must be restricted to a small part of a discretionary mad money portfolio, and should not be placed into a retirement fund.
The first stock he looked at was Accelerate Diagnostics, a company that is developing a diagnostics platform to identify bacteria and viruses and then find out the best drugs to use against them faster than current machines used in medical labs.
Accelerate is still far from profitable, and if it does not receive FDA approval or if there is a delay, Cramer thinks the stock could be obliterated.
"That is what makes it speculative, however, I am confident that the prospects here look good, otherwise I never would have mentioned these guys in the first place," Cramer said.
Though the stock is still extremely risky, Cramer was willing to bless it for speculation at $14 with a potential upside if things go well outweighing the downside if things go wrong.
Read MoreCramer: I'm blessing this spec play for trading